Paving the way to an antivirulence strategy against fungal pathogens: lessons learned from Candida albicans

Papers of special note have been highlighted as: • of interest; •• of considerable interest

References

• 1. Wiederhold NP. Emerging fungal infections: new species, new names, and antifungal resistance. Clin. Chem. 68(1), 83–90 (2021). •• An excellent overview about fungal infection considering the most relevant fungal species in a global perspective.
  MedlineGoogle Scholar
• 2. WHO Fungal Priority Pathogens List to Guide Research, Development and Public Health Action. World Health Organization, Geneva,Switzerland, Licence: CC BY-NC-SA 3.0 IGO (2022). •• A review of the main relevant fungal species able to cause human diseases and their relevance in incidence, prevalence and resistance.
  Google Scholar
• 3. Watkins RR, Bonomo RA. Overview: global and local impact of antibiotic resistance. Infect. Dis. Clin. North Am. 30, 313–322 (2016).
  MedlineGoogle Scholar
• 4. Ivanov M, Ćirić A, Stojković D. Emerging antifungal targets and strategies. Int. J. Mol. Sci. 23(5), 2756 (2022). • A review about the main fungal targets to be used in new chemotherapeutical proposals.
  Medline CASGoogle Scholar
• 5. Tsai CW, Morris S. Approval of raxibacumab for the treatment of inhalation anthrax under the US food and drug administration ‘Animal Rule’. Front. Microbiol. 6, 1320 (2015).
  MedlineGoogle Scholar
• 6. Greig SL. Obiltoxaximab: first global approval. Drugs 76, 823–830 (2016).
  Medline CASGoogle Scholar
• 7. Staniszewska M. Virulence factors in Candida species. Curr. Protein Pept. Sci. 21(3), 313–323 (2020).
  Medline CASGoogle Scholar
• 8. Pierce CG, Lopez-Ribot JL. Candidiasis drug discovery and development: new approaches targeting virulence for discovering and identifying new drugs. Expert Opin. Drug Discov. 8(9), 1117–1126 (2013). •• An excellent overview about antivirulence strategies against Candida species.
  Medline CASGoogle Scholar
• 9. Sá NP, Barros PP, Junqueira JC et al. Antivirulence activity and in vivo efficacy of a thiazole derivative against candidiasis. J. Mycol. Med. 31(2), 101134 (2021).
  MedlineGoogle Scholar
• 10. Croxtall JD, Perry CM. Lopinavir/ritonavir: a review of its use in the management of HIV-1 infection. Drugs 70(14), 1885–1915 (2010).
  Medline CASGoogle Scholar
• 11. Santos ALS, Braga-Silva LA, Gonçalves DS et al. Repositioning lopinavir, an HIV protease inhibitor, as a promising antifungal drug: lessons learned from Candida albicans – in silico, in vitro and in vivo approaches. J. Fungi (Basel) 7(6), 424 (2021).
  Medline CASGoogle Scholar
• 12. Arip M, Selvaraja M, Mogana R et al. Review on plant-based management in combating antimicrobial resistance – mechanistic perspective. Front. Pharmacol. 13, 879495 (2022).
  Medline CASGoogle Scholar
• 13. Lee JH, Kim YG, Choi P et al. Antibiofilm and antivirulence activities of 6-gingerol and 6-shogaol against Candida albicans due to hyphal inhibition. Front. Cell. Infect. Microbiol. 8, 299 (2018).
  MedlineGoogle Scholar
• 14. Albayaty YN, Thomas N, Ramírez-García PD et al. Polymeric micelles with anti-virulence activity against Candida albicans in a single- and dual-species biofilm. Drug Deliv. Transl. Res. 11(4), 1586–1597 (2021).
  Medline CASGoogle Scholar
• 15. Romo JA, Pierce CG, Chaturvedi AK et al. Development of anti-virulence approaches for candidiasis via a novel series of small-molecule inhibitors of Candida albicans filamentation. mBio 8(6), e01991–17 (2017).
  Medline CASGoogle Scholar
• 16. Huang J, Song S, Zhao S et al. Anti-virulence activity of novel (1-heteroaryloxy-2-hydroxypropyl)-phenylpiperazine derivatives against both wild-type and clinical drug-resistant Candida albicans strains. Microb. Biotechnol. 16(1), 116–127 (2023).
  Medline CASGoogle Scholar
• 17. Sun H, Sun K, Sun J. Recent advances of marine natural indole products in chemical and biological aspects. Molecules 28(5), 2204 (2023).
  Medline CASGoogle Scholar
• 18. Manoharan RK, Lee JH, Lee J. Efficacy of 7-benzyloxyindole and other halogenated indoles to inhibit Candida albicans biofilm and hyphal formation. Microb. Biotechnol. 11(6), 1060–1069 (2018).
  Medline CASGoogle Scholar
• 19. Krishna MSA, Mohan S, Ashitha KT et al. Marine based natural products: exploring the recent developments in the identification of antimicrobial agents. Chem. Biodivers. 19(10), e202200513 (2022).
  MedlineGoogle Scholar
• 20. Subramenium GA, Swetha TK, Iyer PM, Balamurugan K, Pandian SK. 5-Hydroxymethyl-2-furaldehyde from marine bacterium Bacillus subtilis inhibits biofilm and virulence of Candida albicans. Microbiol. Res. 207, 19–32 (2018).
  Medline CASGoogle Scholar